Epigenetic dysregulation in neurodegenerative diseases and potential treatment

Epigenetic dysregulation in neurodegenerative diseases and potential treatment

This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.

Détails bibliographiques
Auteur principal:	Mostofa, Golam
Autres auteurs:	Khan, Tanisha Tabassum Sayka
Format:	Thèse
Langue:	English
Publié:	Brac University 2022
Sujets:	Epigenetics Dysregulation Methylation Acetylation Alzheimer’s disease Parkinson’s disease Huntington’s disease Epidrugs
Accès en ligne:	http://hdl.handle.net/10361/17309

Documents similaires

Potential treatments for epigenetic dysregulation in neurological diseases
par: Zaman, Rubaiyat
Publié: (2024)

Investigating the link between Cardiovascular diseases and neurodegenerative disorders
par: Dey, Manashi
Publié: (2024)

Gene editing for neurodegenerative diseases-A review
par: Sharna, Anika Islam
Publié: (2023)

Role of epigenetics in the development of metabolic disorders: a review
par: Mita, Tanzia Mohsin
Publié: (2024)

Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
par: Alim, Abdul
Publié: (2023)

Impact of Lifestyle on the Disease Progression of Parkinson’s
par: Annee, Israt Jahan
Publié: (2023)

Role of circular RNA in neurological disease
par: Salsabil, Labiba
Publié: (2024)

Parkinson’s disease and COVID-19: treatment and patient management during a pandemic
par: Afsana, Nourin
Publié: (2022)

Diagnostic biomarkers of Parkinson’s disease: The present and the future
par: Ferdous, Labiba
Publié: (2023)

Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
par: Chowdhury, Sariya Uzrat
Publié: (2022)

Gender-specific Rhabdomyolysis risk in Alzheimer’s disease patients receiving memantine: a pharmacovigilance study
par: Tabassum, Nadira
Publié: (2024)

Role of protein’s and future treatment options for Alzheimer’s Disease
par: Islam, Md. Irfath
Publié: (2023)

A review on cardiovascular development and epigenetics
par: Srity, Nafisa Alam
Publié: (2024)

A pharmacovigilance study to determine risk of mortality in male and female patients with Alzheimer's disease using Rivastigmine
par: Shehab, Habibul Mohsin
Publié: (2024)

Treatment options of Parkinson’s disease: How far we are from the cure?
par: Afreen, Nuraia
Publié: (2021)

Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
par: Tamanna, Mst. Taskia
Publié: (2023)

Signal detection of Rhabdomyolysis and death for galantamine: a pharmacovigilance study
par: Karmaker, Swastika
Publié: (2024)

Glymphatic system: a pathway for managing endogenous metabolites in CNS
par: Tasneem, Sadia
Publié: (2021)

Comprehensive review on importance, challenges and future prospects of nanotechnology and combination therapy for Alzheimer’s disease
par: Ishrat, Nowshin
Publié: (2024)

Review on: Contribution of nutrients to retard the progression of Alzheimer’s disease
par: Saha, Bithi Rani
Publié: (2023)

Parkinson's disease in Bangladesh: An evaluation of the public knowledge and awareness
par: Chowdhury, Amal
Publié: (2024)

Marine compounds in the treatment of Alzheimer’s disease
par: Parveen, Sanjana
Publié: (2022)

Progress of finding latent therapeutic activity of vaccine for Alzheimer’s disease
par: Hassan, Md. Muhtaz
Publié: (2020)

Review on: the mechanism and function of Glia in parkinson's disease
par: Abedin, Khondokar Mezbahul
Publié: (2023)

Alzheimer's disease and marriage : an intimate account /
par: Wright, Lore K.
Publié: (1993)

Therapeutic implication of senescent cell elimination in neurodegenerative diseases
par: Key, Nasrin Sultana
Publié: (2023)

Emerging therapies of Alzheimer’s disease: a comprehensive review
par: Tasin, Md Abtahi
Publié: (2023)

Biomarkers of Alzheimer’s disease: a hope for early diagnosis
par: Aziz, Farhin
Publié: (2019)

Early detection of parkinson’s disease using image processing and artificial neural network
par: Rumman, Mosarrat, et autres
Publié: (2018)

Prospective detection methods for Tau protein: an important biomarker for Alzheimer’s disease
par: Afra, Sumaiya
Publié: (2022)

A pharmacovigilance study on Memantine: signal detection of Rhabdomyolysis and death
par: Bakar, Osama Bin Abu
Publié: (2024)

Signal detection of rhabdomyolysis and death for rivastigmine: a pharmacovigilance study
par: Mahee, Sadique Abdal
Publié: (2024)

A look into parkinson’s disease and the implications of gene therapy as a novel clinical approach
par: Islam, Md. Rakibul
Publié: (2023)

Application of microRNA (miRNA) in Alzheimer’s Disease (AD)
par: Halim, Rabea
Publié: (2022)

Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
par: Aana, Afsara Sumon
Publié: (2021)

A review of comparison on efficacy, safety and cost effectiveness of cholinesterase inhibitors, NMDA antagonists and combination therapy in the treatment of Alzheimer’s disease
par: Haque, Mushfiqul
Publié: (2019)

A pharmacovigilance study on Donepezil: signal detection of rhabdomyolysis and death
par: Jahan, Nusrat
Publié: (2023)

Infection and communicable diseases /
par: Brettle, Raymond Patrick
Publié: (1984)

Exploring Alzheimer's disease prediction with XAI in various neural network models
par: Rahman, Quazi Ashikur, et autres
Publié: (2022)

Exploring the potential of organic molecules in the treatment of covid-19
par: Mondol, Winifred Claire
Publié: (2024)